Cochrane Review: Omega-3 fatty acid supplementation for depression in children and adolescents

Zusammenfassung

Omega‐3‐Fettsäure‐Supplementierung bei Depressionen im Kindes‐ und Jugendalter - Campisi, SC - 2024 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014803.pub2/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014803.pub2/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to tu

Kerninformationen

abase of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention Collapse all Expand all ## Abstract available in ### Background Mental health disorders including major depressive disorder (MDD) are well recognized as major contributors to the...

o moderate MDD, and adjunctive to antidepressants for adults with moderate to severe MDD. The benefits of omega‐3 PUFA intake on depressive illness have been hypothesized to occur as a result of their effect on neurotransmission, maintenance of membrane fluidity, and anti‐inflammatory action. A comp...

tandard care) on clinician‐diagnosed depression or self‐reported depression symptoms in children and adolescents. **Secondary objectives** To estimate the size of the effect of omega‐3 PUFAs on depression symptoms. To estimate the effect of each type of omega‐3 PUFA (EPA or DHA), compared with pl...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen